The potential of Trichoderma fungi as biocontrol agents has not yet been fully explored, as there is a large repertoire of inter- and intra-species variation in their phytopathogenic antagonistic effects due to different adaptations of individual Trichoderma strains. In the present study, we investigated the biocontrol efficacy of eight native isolates of Trichoderma spp. against the soilborne phytopathogens Sclerotinia sclerotiorum and Rhizoctonia solani and a representative of the Mucoromycota, Phycomyces blakesleeanus. An in vitro dual culture test showed a complete (100%) inhibition of S. sclerotiorum and P. blakesleeanus by each tested Trichoderma strain and a high (80–100%) inhibition of R. solani. The crude chloroform extracts, whose peptide contents were confirmed by thin-layer chromatography, caused a concentration-dependent reduction in the growth of the target fungi, with inhibition comparable to the effect of the peptaibol standard alamethicin. Despite the differences between fungi from the phyla Basidiomycota, Ascomycota, and Mucoromycota, their inhibition by alamethicin followed the same dose–response dependence. The growth inhibition of P. blakesleeanus induced by Trichoderma extracts was characterized by a significantly increased activity of antioxidative defense enzymes. Both variants of biocontrol agents, the native strains of Trichoderma spp. and their extracts, are efficient in controlling fungal growth and should be considered for the development of new potent bioformulations applicable in agriculture.
8 July 2025 in World Journal of Microbiology and Biotechnology
Understanding the effect of vanadate (V(V)) on the well-studied filamentous fungus, Phycomyces blakesleeanus, is of great importance for establishing the mechanisms of vanadium internalisation and metabolism. Although P. blakesleeanus is not a soil fungus, its short life cycle and evolutionary basal position in the fungal kingdom makes it an excellent model for studying the interactions of fungi with vanadate and other metals as well as the improvement of their use in vanadium recovery (bioaccumulation) and the remediation of contaminated soils. In this study, we investigated the effects of vanadate at three concentrations (1 mM, 5 mM, and 10 mM) on both enzymatic and non-enzymatic components of the antioxidant system of mycelia at different growth stages. The production of ROS was highest in the exponential phase, but its reducing capacity was maintained, probably due to high levels of non-enzymatic antioxidants such as phenols and glutathione. In the stationary phase, while the reducing capacity of the mycelia was somewhat impaired by vanadate (V(V)), it recovered due to the action of the glutathione system and the activation of peroxidases. In the late exponential/early stationary phase, no significant activation of the antioxidative systems was observed, and the reducing capacity was impaired. When we consider the effects of V(V) on mycelial growth, this was the only phase with reduced viability, while the exponential and stationary phases were unaffected, if not stimulated. This study provides insight into the tolerance of P. blakesleeanus mycelia to vanadate, even at concentrations as high as 10 mM, making this fungus a good candidate for V(V) bioaccumulation.
Coprinus comatus is an edible mushroom with potential antidiabetic properties. This study aimed to evaluate the hypoglycemic and protective effects of lyophilized and powdered fruiting bodies of Coprinus comatus in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced in the animals by intraperitoneal injection of STZ (30 mg/kg/day for four consecutive days), and hyperglycemia was confirmed 24 h after the final STZ dose. Diabetic rats were orally treated with powdered C. comatus fruiting bodies for four weeks following the final STZ administration. Biochemical parameters, including fasting blood glucose levels, oxidative stress markers, and the extent of tissue DNA damage, were evaluated. The results showed that C. comatus significantly lowered blood glucose levels, improved antioxidant enzyme activities, and reduced DNA damage in kidney tissue. These findings suggest that C. comatus exerts antidiabetic effects by improving glycemic control, lowering blood glucose levels, and reducing kidney DNA damage in diabetic rats to levels comparable with those of the control group, highlighting its potential as a complementary therapeutic agent in diabetes management.
Graphical Mycelia of Phycomyces blakesleeanus were incubated for 24 h in V(V) at three different growth stages: mid-exponential (20 h), late exponential/early stationary (36 h) and stationary (56 h). The uptake of V(V) was highest in the mid-exponential stage, while a significant increase in the lipid/amide I ratio was observed in both the mid-exponential and late exponential/early stationary stages.